University of Khartoum) advocated in the management of diabetic ketoacidosis, but none has been generally accepted. Some authors stress the importance of ketonaemia in deciding the initial dose of insulin, and others are guided by blood glucose levels. In the presence of severe ketoacidosis amounts of 300-400 IU of insulin have been advocated (Bradley, 1971; Hockaday and Alberti, 1972) . Most regimens include complex advice about further doses to be given every two or four hours according to the response of the blood glucose. There is a common impression that the more severe the acidosis the more insulin is needed (Phear, 1963) though recent work has cast doubt on this (Hockaday and Alberti, 1972) . In one prospective study no difference in clinical response was found between groups of patients receiving 80, 160, or 240 IU of insulin initially (Smith and Martin, 1954) .
There is no valid evidence that large doses of insulin are needed, and they may carry risks, in particular hypokalaemia (Alberti, 1974) , hypoglycaemia, and hyperlactataemia (Alberti et al., 1973) . Over the last 50 years occasional reports have appeared on the use of small doses of insulin (Faber and Holst, 1927; Katsch, 1946; Menzel and Jutzi, 1970 ), but they have had little impact on clinical practice. In normal subjects maximal hypoglycaemic activity is achieved by blood insulin levels in the range of .tU/ml (Christensen, 1968; Sonksen, et al. 1973 ). Sonksen et al. (1972) have also shown that the rate of fall of blood glucose in uncontrolled diabetes is uniformly rapid with blood insulin concentrations in this range, and that these concentrations can be achieved by insulin infusion at rates of 2-12 IU/hr. Alberti et al. (1973) used small hourly doses of insulin given intramuscularly to achieve blood concentrations in this range and found them to be effective in ketoacidotic patients.
The technique of constant intravenous infusion offers advantages over intermittent dose regimens-insulin action begins at once and a steady blood concentration in the effective range can be maintained and can be altered or ended almost instantaneously. Since the half life of insulin in blood is between three and five minutes (Turner et al., 1971; Sonksen et al., 1973 (Williamson et al., 1962) , lactate and pyruvate (Hohorst et al. 1959) , and glycerol (Kreutz, 1962) . Plasma free fatty acids (F.F.A.) were measured colorimetrically (Duncombe, 1963; Itaya and Ui, 1965 Plasma glucose ranged from 295-2,010 mg/100 ml, mean 809 ± 57, and blood ketone body concentrations from 2 7-18.6 mmol/l., mean 11-3 ± 0 -8 (n = 25). Other mean values were blood urea 92 ± 11 mg/100 ml (n = 38), lactate 2-11 ± 0-21 mmol/l. (n 24), pyruvate 0-092 ± 0-010 mmol/l. (n = 15), glycerol 0-24 ± 0 03 mmol/l. (n = 15), and plasma F.F.A. 1 64 ± 0.26 mmol/l. (n 13). Serum potassium ranged from 2 8-8-4 mEq/l., mean 5-3 ± 0 8. In the 17 patients who had never previously received insulin admission concentrations averaged 5 suU/ml and ranged from unrecordable-that is, <2 FU/ml-to 14 ,uU/ml.
TREATMENT
Insulin.-On admission all patients received intravenous normal saline, and insulin infusion was begun a quarter of an hour to three hours afterwards. At King's College Hospital insulin was administered as follows: 24 IU of soluble insulin was added to a plastic syringe and the volume made up to 20 ml with saline.
Using a mechanical pump the insulin was given in all but one case at a rate of 5 ml (6 IU) hourly via a four-way tap directly into the intravenous fluid line. A fresh insulin solution was prepared every four hours immediately before use. The rate of insulin administration was independent of the intravenous drip flow rate. At the other centres the procedure was similar but 0 5 g/100 ml human albumin (Lister Institute) was added to the insulin solution, and the solution was administered at rates from 3-24 IU/hr (average 8-6 IU/hr). Saline and insulin infusion was continued until the plasma glucose was between 100 mg and 250 mg/ 100 ml, when glucose infusions were begun. On termination of the insulin infusion subcutaneous insulin was given immediately and as needed.
Intravenous Fluids.-Normal saline (0154 mol/l.) was infused initially. This was changed to half-strength saline in the four patients with plasma sodium above 155 mEq/l. A mean of 3-66 1.
(range 1.5-6) was given in the first six hours and 5-51 1. (range 2-75-9 There was no significant difference in this relatively small study in plasma glucose response according to age, severity of acidosis, or previous treatment with insulin. The magnitude of fall by four hours was 59% in the 10 patients with the highest blood ketones compared with 55% in the 10 with the lowest ketones. In the six patients with proven bacterial infections the fall at four hours was 33% compared with 60% in those without infection (0-1 > P >0 05). 
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,X(13) v U C of insulin was effective in the 38 cases in this study. The technique of intravenous infusion in diabetic coma was first described in 1960 (Rossier et al., 1960; Volim, 1960 ) with an initial dose of 100 IU/hr, and further reports have followed using doses of 100 IU (Froesch et al., 1966) and 50 IU/hr (Genuth, 1973) . Infusion of low dose of insulin was first described by Sonksen et al. (1972) , who used amounts from 1-5-12 IU/hr. Low dose insulin infusion maintains adequate blood concentrations of insulin. In 70-kg adults an infusion rate of 6 IU/hr produces an average steady state serum insulin concentration of 100 ,U/ml, but biological variation between patients in the factors determining the pharmacokinetics of insulin metabolism results in observed serum insulin concentrations ranging from 20 to 200 iLU/ml. (Sonksen et al., 1972 (Sonksen et al., , 1973 . In children a dose of 0 1 IU/kg/hr is theoretically sufficient to achieve an average blood insulin concentration of 100 ,U/ml. (Sonksen et al., 1973) . % Though continuous infusion is the most direct way of giving insulin previous work has discouraged its use. Insulin is variably adsorbed to glass and plastic, an effect which can be almost completely abolished by the addition of a small amount of human albumin to the insulin solution (Sonksen et al., 1965) . Weisenfeld et al. (1968) showed that the adsorption of insulin from non-protein-containing solutions may approach 30-40% depending on its concentration, the time in contact with an adsorbing surface, and the rate of flow and that adsorption is inhibited by the presence of negatively charged proteins such as human serum albumin. The degree of adsorption seems to be negligible when insulin is present in relatively high concentrations in the infusion syringe. Serum insulin concentrations and plasma glucose response were similar in our patients who were treated with and without albumin, and its addition therefore seems unnecessary. With insulin doses in the range used in this study the variability 'of adsorption due to different types and makes of plastic materials should not be important.
High doses of insulin have previously been used to anticipate insulin "resistance," thought to be a risk in some patients with severe acidosis, infection, or an excess of insulin antibodies. A striking feature in the present series was the lack of effect of ketoacidosis or previous insulin treatment on the glucose response to insulin. Alberti et al. (1973) , using small doses of insulin given intramuscularly, also found a uniform response and did not encounter insulin resistance. The only patient to show a rise in plasma glucose during insulin infusion was the man who had two cardiac arrests. He had shown signs of early metabolic improvement-that is, a fall of ketones from the start of treatment-and had received a large dose of hydrocortisone, an insulin antagonist. His plasma glucose fell satisfactorily when the infusion rate was increased to 12 IU/hr. It is a simple matter to raise the circulating insulin concentration if the metabolic response is inadequate by increasing the infusion rate, when a new steady state is obtained within 10 minutes.
The rate of fall of blood glucose during low dose insulin infusion is similar to that when insulin is given by other routes in larger amounts. In the present series the mean plasma glucose four hours after insulin infusion had fallen by 58%, which is similar to the results in a previous series of 100 cases at King's College Hospital using conventional high doses of insulin given by intravenous and intramuscular injections (Sheldon and Pyke, 1968) . Alberti et al. (1973) had similar results with a regimen of small intramuscular doses hourly. Furthermore, the rate of fall of plasma glucose was no greater with an insulin infusion rate of 50 IU/hr (Genuth, 1973) . Blood glucose is known to fall with saline infusion alone (Alberti et al., 1973) , as was observed in 12 of 18 of our patients, but the rate of fall increases when insulin is added. Early and adequate intravenous fluid replacement remains an essential part of the treatment of diabetic "coma" whatever insulin treatment regimen is used.
There was a more rapid fall in 3-hydroxybutyrate than in acetoacetate (Stephens et al., 1971) . By five hours after the start of insulin the ratio of 3-hydroxybutyrate to acetoacetate had fallen to about 1, suggesting an earlier return to normal of the mitochondrial redox state (Gumaa et al., 1971) .
The danger of hypokalaemia may be lessened by using small doses of insulin (Alberti et al., 1973) . Large doses of insulin seem to lead to a faster fall of plasma potassium, probably because of increased uptake in peripheral tissues. In our cases, relatively small amounts of potassium were added, but hypokalaemia was not a problem. It is possible that the steady insulin concentrations we achieved were effective in inhibiting hepatic gluconeogenesis without stimulating peripheral uptake of glucose and thus led to a fall in blood glucose without marked uptake of potassium by peripheral tissues.
The method described here is simple and involves no complicated calculation of insulin dosage according to clinical state or biochemical findings. About 6 IU/hr given by continuous infusion was found to be a safe starting dose and this can be halved or doubled hourly at will on the basis of response to treatment. A standard regimen simplifies management for medical and nursing staff, but it should not lead to a false sense of security, as diabetic "coma" remains a medical emergency. Blood glucose and electrolytes need to be measured often and the results must be available quickly whatever type of treatment is used.
The technique of continuous intravenous infusion of low doses of insulin seems also to be suitable for the management of unstable or refractory diabetes in other circumstances-for example, after myocardial infarction or operation and during labour.
The use of a continuous infusion of insulin in low dose seems to have advantages over standard large dose regimens in the treatment of diabetic "coma" and in our experience has proved simple, safe, and effective.
